The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

1. In order to explore potential therapeutic implications of cannabinoid antagonists, the effects of the prototypical cannabinoid antagonist SR141716A on monoamine efflux from the medial prefrontal cortex and the nucleus accumbens of the rat were investigated by in vivo microdialysis. 2. SR141716A m...

Full description

Saved in:
Bibliographic Details
Main Authors: Tzavara, Eleni T, Davis, Richard J, Perry, Kenneth W, Li, Xia, Salhoff, Craig, Bymaster, Frank P, Witkin, Jeffrey M, Nomikos, George G
Format: Artigo
Language:Inglês
Published: 2003
Subjects:
Papers
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1573706/
https://ncbi.nlm.nih.gov/pubmed/12598408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705100
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items